Cancer Therapy and Research Center CTRC at UTHSCSA

San Antonio, Texas 78229

0 studies enrolling now · 1 studies all time

What they study most

HER2-Negative Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer, Locally Advanced or Early Breast Cancer

Studies at this site

• Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer — Completed